January 8, 2010 - The Prostate Cancer Foundation (PCF) will fund at least 10 new Creativity and 20 new multi-year Young Investigator Awards in the first half of 2010 to support innovative research in the field of cancer research.

This new round of funding will support many projects that would otherwise be left unfunded due to cutbacks in federal funding and the global recession.

"We are delighted to announce that we will be funding more than 30 new game-changing research projects in 2010 in addition to the 48 research programs that we are already supporting," commented Jonathan W. Simons, M.D., president, CEO, and David H. Koch, chair of the Prostate Cancer Foundation.

"The commitment of our donors enables us to continue advancing cancer research at a time when other funding sources are shrinking. In 2009, PCF donors contributed more than U.S. $36.5 million-just shy of our 2008 total of $37.2 million-to support PCF's research enterprise. Gifts to the PCF ranged from $5.00 to $5 million. We are grateful to our supporters, both large and small, for making ongoing research progress against prostate cancer possible," they said in a public statement.

PCF funded 10 Creativity Awards in 2009 and 20 Young Investigators in 2008. The foundation will release its list of 2010 Young Investigators in March. The deadline for the Creativity Awards Request for Applications is January 31.

"PCF's Creativity and Young Investigator programs are designed to accelerate scientific research and discovery for funding new treatments and ultimately cures for this disease," commented Howard Soule, Ph.D., PCF's chief science officer responsible for overseeing the foundation's funded research programs. "Traditionally, 70 percent of our Creativity Award recipients go on to earn additional funding for their programs. Our Young Investigators are the human capital bringing new ideas to cancer research. They are energizing the fight against prostate as well as other cancers."

For more information: www.pcf.org


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now